PAG
CASI

Private Advisor Group’s CASI Pharmaceuticals CASI Stock Holding History

Private Advisor Group’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-14
Closed – – 1836
2020
Q2 		$0 Buy
+14
New +$304 ﹤0.01% 3842
2018
Q4 		– Sell
-1,500
Closed -$70K – 1384
2018
Q3 		$70K Hold
1,500
– – ﹤0.01% 1555
2018
Q2 		$122K Hold
1,500
– – ﹤0.01% 1242
2018
Q1 		$63K Buy
+1,500
New +$56K ﹤0.01% 1121

Other funds holding CASI

IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Private Advisor Group's CASI Position: Q3 2020 in Review

Private Advisor Group sold out of CASI Pharmaceuticals (CASI) in Q3 2020, closing a stake of 14 shares.

Private Advisor Group first reported a position in CASI in Q1 2018 and held it in 4 quarters. The position peaked at $122K in Q2 2018. 67 funds tracked by Wall St. Rank hold CASI as of Q3 2020.

  • Private Advisor Group reported no remaining CASI Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 14 CASI Pharmaceuticals shares in Q3 2020.
  • Private Advisor Group first reported a position in CASI Pharmaceuticals in Q1 2018 and held it in 4 quarters.
  • Private Advisor Group's CASI Pharmaceuticals position peaked at $122K in Q2 2018.
  • 67 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.